Sharada Mailankody

Sharada Mailankody

Auto-generated profile, based on publicly available information

Sharada Mailankody

Department of Medical Oncology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in ESMO Open
Verified
Journal Article
Open access
PDF file
JBJyoti Bajpai
Jyoti Bajpai
SMSharada Mailankody
Sharada Mailankody
RNReena Nair
Reena Nair
SSShylasree T Surappa
Shylasree T Surappa
SGSudeep Gupta
Sudeep Gupta
GBGovind Babu
Govind Babu
Introduction There is evidence of under-representation of women in leadership roles and publications in oncology. However, there is little knowledge about their perceptions of professional environment, unique challenges and opportunities compared with male counterparts. The problem is more prominent in lower-income and middle-income countries like India and merits exploration. Materials and methods A survey, ‘Exploratory Study on the Challenges of Female Oncologists in India’, was conducted among oncology professionals. We included questions on demography, working team details, role at work, perceived challenges for advancement of career, gender-related values brought into the team and the measures for improvement of gender disparity. Lead authorship data were collected from two Indian oncology journals. Results Of the 324 respondents, 198 (61.1%) were women. Majority of the respondents were medical oncologists (46.3%), ≤45 years old (69.4%) and working in universities and corporate hospitals (71.6%). One hundred eighty-nine (58.3%) respondents worked in teams with male majority, 50 (15.4%) in women-majority teams, while 85 (26.2%) worked in teams with gender equality. Of the 324 respondents, 218 (67.3%) had men managers, while 106 (32.7%) had women managers. Men led 160 (84.7%) male-majority teams; 45 (52.9%) gender-equal teams; and 13 (26%) female-majority teams (p45 years was found to be associated with a leadership role (43% vs 25%, p=0.0012). The most significant barrier perceived for advancement of career for women was finding a work–life balance. Most respondents suggested provision of flexible training programmes to improve the disparity. Of the 558 journal publications inspected, 145 (26%) articles had a female first or corresponding author. Conclusions The study brought out the current figures regarding gender climate in oncology practice and academia across India. We identified lead thrust areas and schemes to improve the gender bias. There needs to be action at international, national and personal levels to bring about an efficient gender-neutral workforce.

27 February 2023 in The Lancet Regional Health - Southeast Asia
Verified
Journal Article
Open access
SMSharada Mailankody
Sharada Mailankody
JBJyoti Bajpai
Jyoti Bajpai
ABAtul Budukh
Atul Budukh
RSRajaraman Swaminathan
Rajaraman Swaminathan
RDRajesh Dikshit
Rajesh Dikshit
ATAnnalisa Trama
Annalisa Trama
Rare cancers (RCs) are challenging to manage and are "forgotten cancers" though they collectively constitute a significant proportion of all cancers (∼20%). As a first step towards streamlining care, there is an unmet need to map the epidemiology of RCs in South Asian Association for Regional Collaboration (SAARC) countries. The authors collected data from 30 Population-Based Cancer Registries (PBCR) of India and the published national registries of Nepal, Bhutan and Sri Lanka (SL) and compared them with the standard RARECAREnet RC list. With the standard definition of crude incidence rates (CR) ≤6/100,0000 per population, 67.5%, 68.3%, 62.3% and 37% of all incident cancers qualify as RCs in India, Bhutan, Nepal and SL, respectively. An arbitrary cut-off CR ≤3 appears more appropriate with 43%, 39.5%, 51.8% and 17.2% of cancers identified as RCs, respectively, due to the lower cancer incidence.There are similarities and notable differences between the RC lists of the SAARC region with that of the European RC list. Oral cavity cancers are rare in Europe, while pancreas, rectum, urinary bladder and melanomas are common. In addition, uterine, colon and prostatic cancers are rare in India, Nepal and Bhutan. In SL, thyroid cancer is common. There are gender-related and regional differences in RC trends in the SAARC countries. There is an unmet need in SAARC nations to capture epidemiological nuances in rare cancers. Understanding the unique issues in the developing world may guide policymakers to adopt appropriate measures to improve RC care and tailor public health interventions. None.

31 December 2021 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
SMSharada Mailankody
Sharada Mailankody
VKVenkatesan Sampath Kumar
Venkatesan Sampath Kumar
SKShah Alam Khan
Shah Alam Khan
SBShripad D. Banavali
Shripad D. Banavali
JBJyoti Bajpai
Jyoti Bajpai

2 August 2024 in Cancer Epidemiology
Verified
Journal Article
Closed access
VNVanita Ann Noronha
Vanita Ann Noronha
ARAbhijith Rajaram Rao
Abhijith Rajaram Rao
APAnupa Pillai
Anupa Pillai
AKAnita Kumar
Anita Kumar
SRSenthil Rajappa
Senthil Rajappa
KPKumar Prabhash
Kumar Prabhash

1 June 2024 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
SMSharada Mailankody
Sharada Mailankody
VGVishwapriya Mahadev Godkhindi
Vishwapriya Mahadev Godkhindi
KUKarthik Udupa
Karthik Udupa
APAnanth Pai
Ananth Pai
ABAtul Budukh
Atul Budukh
SRSwaminathan Rajaraman
Swaminathan Rajaraman
Introduction: Indian population is aging and the cancer rates are rising. Older adults (OAs)(≥60 years) with cancer require specialized care. However, data on geriatric cancer epidemiology is scarce. Methods: The study compiled the geriatric cancer data from the published reports(2012-2014) of Indian population-based cancer registries(PBCRs). Results: Of the 1,61,363 cancers registered in the Indian PBCRs, 72,446(44.9%) occur in OAs, with 21,805(30.1%), 18,349(25.3%), 14,645(20.2%), and 17,647(24.4%) occurring in 60-64, 65-69, 70-74, and ≥75year age groups. The truncated incidence rates for OAs are 555.9,404.5, and 481.9 for males, females, and OA populations respectively. The common cancers are lung, prostate, and esophagus cancers in males, breast, cervix, and lung in females. The overall common cancers are lung, prostate, and breast. While >50% of the incident cases of prostate, and bladder cancers occurred in OAs, <20% of Hodgkin lymphoma and thyroid cancers occurred in OAs. OA cancer epidemiology has a regional variation, highest in South India and lowest in Western India.Conclusion: The current study quantifies the cancer burden in the Indian geriatric population. Understanding the epidemiology of geriatric cancers is vital to health program planning and implementation. Increased awareness, focused resource allocation, research, and national policies for streamlining care will all help to improve geriatric cancer outcomes.

14 December 2022 in Supportive Care in Cancer
Verified
Journal Article
Open access
PDF file
SMSharada Mailankody
Sharada Mailankody
PSPrathika Sherigar
Prathika Sherigar
APAnanth Pai
Ananth Pai
RSRamnath Shenoy
Ramnath Shenoy
KUKarthik Udupa
Karthik Udupa
SRSeema R. Rao
Seema R. Rao
Purpose: Breaking bad news (BBN) is a vital part of oncology practice. We conducted this study to assess an abbreviated PENS protocol [Patient preference, Explanation, Next appointment, and Support] for BBN in oncology outpatient (OP) settings. Methods: This observational study was conducted in a university teaching hospital, including cancer patients who were unaware of their condition and willing to discuss their disease status. The duration of BBN was the primary outcome. After the BBN session, patients filled a validated questionnaire; response scores of ≤ 13 were classified as content with BBN. Results: Fifty patients (mean age 53.7 years, range 28–76) were included in the study. The average duration of BBN was 6.1 (range 2–11) min. Assessed by the response score sum, 43 (86%) patients were satisfied with BBN. Only three (6%) of the discontented patients felt that the BBN duration was too short. Most (94%) of patients reported that they understood the information imparted during the BBN session. After the session, 36 (72%) patients admitted to either feeling the same or reassured compared to before the session. The oncologists also were comfortable with PENS. Conclusions: The PENS approach is a practical method for BBN, especially when the oncologists have higher OP workloads. More extensive trials are required to validate the protocol in other settings. Trial registration: Clinical Trial Registry of India (CTRI/2021/07/034707).